Jun 2, 2026 08:01AM
Jun 2, 2026 08:00AM
May 14, 2026 08:03AM
May 14, 2026 08:00AM
Mar 18, 2026 08:00AM
Feb 17, 2026 08:02AM
Feb 17, 2026 08:00AM Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Nov 13, 2025 08:00AM
Nov 10, 2025 08:01AM
Nov 10, 2025 08:00AM
Oct 28, 2025 08:01AM
Oct 28, 2025 08:00AM
Oct 14, 2025 08:04AM
Oct 14, 2025 08:00AM FDA Accepts Cingulate’s New Drug Application for CTx-1301 in Attention-Deficit/Hyperactivity Disorder (ADHD) and sets a May 31, 2026 PDUFA Date
Aug 19, 2025 08:45AM
Jul 29, 2025 08:01AM
Jul 29, 2025 08:00AM

15,434 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All